Washington, DC, United States of America

Werner Tueckmantel


Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Washington, DC (US) (2001 - 2007)
  • Yorktown Heights, NY (US) (2013 - 2014)

Company Filing History:


Years Active: 2001-2014

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Werner Tueckmantel

Introduction

Werner Tueckmantel is a notable inventor based in Washington, DC, with a significant portfolio of 11 patents. His work primarily focuses on advancements in medical treatments and pharmaceutical compositions, showcasing his commitment to improving health outcomes.

Latest Patents

Among his latest patents, one invention relates to isoform-selective HDAC inhibitors. This invention includes methods for sensitizing cancer cells to the cytotoxic effects of radiotherapy. Additionally, it provides methods for treating cancer, neurological diseases, and malaria. The invention also encompasses pharmaceutical compositions that include an HDAC inhibitor and kits containing the same. Another significant patent involves pyridinyl nicotinic acetylcholine receptor ligands, which are used to treat or prevent conditions such as depression and nicotine dependence. This patent outlines methods for administering effective amounts of these ligands to animals in need.

Career Highlights

Werner Tueckmantel has made substantial contributions to the field of medical research through his innovative inventions. His work has been instrumental in developing new therapeutic approaches that address critical health issues.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues, including Alan P Kozikowski and Leo J Romanczyk. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Werner Tueckmantel's contributions to the field of medical innovation are significant, with a focus on developing treatments for various diseases. His patents reflect a dedication to advancing healthcare through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…